MiNK Therapeutics, Inc. Profile Avatar - Palmy Investing

MiNK Therapeutics, Inc.

MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated dis…

Biotechnology
US, New York [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of INKT's Analysis
CIK: 1840229 CUSIP: 603693102 ISIN: US6036931029 LEI: - UEI: -
Secondary Listings
INKT has no secondary listings inside our databases.